B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis

Journal of Immunology

Volumn 167, Issue 3, 2001, Pages 1830-1838

  Liu, Z ^a   Geboes, K ^a   Hellings, P ^a   Maerten, P ^a   Heremans, H ^a   Vandenberghe, P ^a   Boon, L ^a   Van Kooten, P ^a   Rutgeerts, P ^a   Ceuppens, J L ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 0035425004     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.3.1830     Document Type: Article

References (54)

1. Inflammatory bowel disease: Etiology and pathogenesis
2. Current theories on the causes of inflammatory bowel disease
3. CD28/B7 system of T cell costimulation
4. Differential T cell costimulatory requirements in CD28-deficient mice
5. Absence of B7-dependent responses in CD28-deficient mice
6. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions
7. Expression of functional B7 and CTLA4 on rheumatoid synovial T cells
8. Discordant expression of CD28 ligands, BB-1, and B7 on keratinocytes in vitro and psoriatic cells in vivo
9. Mucosal expression by B7-positive cells of the 60-kilodalton heat-shock protein in inflammatory bowel disease
10. Differential distribution of B7.1 (CD80) and B7.2 (CD86) costimulatory molecules on mucosal macrophage subsets in human inflammatory bowel disease (IBD)
11. Distinct roles of B7.1 (CD80) and B7.2 (CD86) in the initiation of experimental allergic encelophalomyelitis
12. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy
13. Blockade of CD28/B7.1 interaction prevents epitope spreading and clinical relapses of murine EAE
14. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
15. Costimulation through B7-2 (CD86) is required for the induction of a lung mucosal T helper cell 2 (TH2) immune response and altered airway responsiveness
16. Development of murine allergic asthma is dependent upon B7-2 costimulation
17. Treatment of murine lupus with CTLA4Ig
18. Collagen-induced arthritis in the BB rat: Prevention of disease by treatment with CTLA-4-Ig
19. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4Ig
20. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines bur spares Th2
21. CD28-deficient mice are highly resistant to collagen-induced arthritis
22. Studies in B7-deficient mice reveal a critical role for BT costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis
23. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28
24. A new member of the immunoglobulin superfamily CTLA-4
25. CTLA-4 can function as negative regulator of T cell activation
26. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells
27. CTLA-4 ligation blocks CD28-dependent T cell activation
28. CTLA-4 mediates antigen-specific apoptosis of human T cells
29. Expression and function of CTLA-4 in Th1 and Th2 cells
30. Enhancement of antitumor immunity by CTLA-4 blockade
31. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4
32. Loss of CTLA-4 leads to massive lymphoproliferation and fetal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
33. CTLA-4: A negative regulator of autoimmune disease
34. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyetitis
35. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
36. + T cells by blocking the CD40-CD154 interactions
37. Role of interleukin-12 in the induction of mucosal inflammation and abrogation of regulatory T cell function in chronic experimental colitis
38. + regulatory cells that control intestinal inflammation
39. Chronic murine colitis is dependent on the CD154/CD40 pathway and can be attenuated by anti-CD 154 administration
40. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells
41. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation
42. + cytotoxic T lymphocyte-associated antigen 4
43. Regulatory T cells in autoimmunnity
44. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
45. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
46. Analysis of the site of interaction of CD28 with its counterreceptors CD80 and CD86 and correlation with function
47. Role of costimulation in the induction of the IL-12/IL-12 receptor pathway and the development of autoimmunity
48. An intra-peyer's patch gene transfer model for studying mucosal tolerance: Distinct role of B7 and IL-12 in mucosal T cell tolerance
49. Visualizing the generation of memory CD4 T cells in the whole body
50. Increased expression of IL-12 receptor β1 and β2 mRNA in Crohn's disease compared to ulcerative colitis and induction of β2 by costimulation with B7-1 molecules
51. + T cells
52. B7.1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28
53. CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion
54. + T cells